Scientists at the University of California-San Diego say they have moved one step closer to the ability to make heparin in cultured cells. Heparin is a potent anti-coagulant and the most prescribed drug in hospitals, yet cell-culture-based production of heparin is currently not possible, according to the researchers who published their study, ZNF263 is a transcriptional regulator of heparin and heparan sulfate biosynthesis in PNAS.
In particular, the researchers found a critical gene in heparin biosynthesis: ZNF263 (zinc-finger protein 263). The team believes this gene regulator is a key discovery on the way to industrial heparin production. The idea would be to control this regulator in industrial cell lines using genetic engineering, paving the way for safe industrial production of heparin in well-controlled cell culture.
Heparin is the most widely prescribed biopharmaceutical in production globally. Its potent anticoagulant activity and safety makes it the drug of choice for preventing deep vein thrombosis and pulmonary embolism. In 2008, adulterated material was introduced into the heparin supply chain, resulting in several hundred deaths and demonstrating the need for alternate sources of heparin. Heparin is a fractionated form of heparan sulfate derived from animal sources, predominantly from connective tissue mast cells in pig mucosa. While the enzymes involved in heparin biosynthesis are identical to those for heparan sulfate, the factors regulating these enzymes are not understood, write the investigators.
Examination of the promoter regions of all genes involved in heparin/heparan sulfate assembly uncovered a transcription factor-binding motif for ZNF263, a C2H2 zinc finger protein. CRISPR-mediated targeting and siRNA knockdown of ZNF263 in mammalian cell lines and human primary cells led to dramatically increased expression levels of HS3ST1, a key enzyme involved in imparting anticoagulant activity to heparin, and HS3ST3A1, another glucosaminyl 3-O-sulfotransferase expressed in cells. Enhanced 3-O-sulfation increased binding to antithrombin, which enhanced Factor Xa inhibition, and binding of neuropilin-1. Analysis of transcriptomics data showed distinctively low expression of ZNF263 in mast cells compared with other (nonheparin-producing) immune cells. These findings demonstrate a novel regulatory factor in heparan sulfate modification that could further advance the possibility of bioengineering anticoagulant heparin in cultured cells.
The UC San Diego scientists reasoned that heparin synthesis must be under the control of transcription factors, whose tissue-specific occurrence might give mast cells the unique ability to produce heparin. Since regulators for heparin were not known, a research team led by UC San Diego professors Jeffrey Esko, PhD, and Nathan Lewis, PhD, used bioinformatic software to scan the genes encoding enzymes involved in heparin production and specifically look for sequence elements that could represent binding sites for transcription factors. The existence of such a binding site could indicate that the respective gene is regulated by a corresponding gene regulator protein, i.e. a transcription factor.
One DNA sequence that stood out the most is preferred by a transcription factor called ZNF263 (zinc-finger protein 263), explains Lewis, who holds appointments in the UC San Diego School of Medicines Department of Pediatrics and in the UC San Diego Jacobs School of Engineerings Department of Bioengineering.
Using CRISPR/Cas9, the researchers mutated ZNF263 in a human cell line that normally does not produce heparin. They found that the heparan sulfate that this cell line would normally produce was now chemically altered and showed a reactivity that was closer to heparin. Experiments further showed that ZNF263 represses key genes involved in heparin production. Analysis of gene expression data from human white blood cells showed suppression of ZNF263 in mast cells (which produce heparin in vivo) and basophils, which are related to mast cells. The researchers report that ZNF263 appears to be an active repressor of heparin biosynthesis throughout most cell types, and mast cells are enabled to produce heparin because ZNF263 is suppressed in these cells.
This finding could have important relevance in biotechnology. Cell lines used in industry (such as CHO cells that normally are unable to produce heparin) could be genetically modified to inactivate ZNF263 which could enable them to produce heparin, like mast cells do.
Philipp Spahn, PhD, a project scientist in the Lewis lab, described further directions the team is pursuing: Our bioinformatic analysis revealed several additional potential gene regulators which can also contribute to heparin production and are now exciting objects of further study.
See the original post:
Researchers Move Closer to Industrial Production of Heparin in Cell Culture - Genetic Engineering & Biotechnology News
- Angel Biotechnology (ABH) - Video [Last Updated On: November 28th, 2011] [Originally Added On: November 28th, 2011]
- Curing the entire world through biotechnology [Last Updated On: December 18th, 2011] [Originally Added On: December 18th, 2011]
- Biotechnological innovation on Farming Skill [Last Updated On: December 18th, 2011] [Originally Added On: December 18th, 2011]
- Growth and development of Biotechnology [Last Updated On: December 18th, 2011] [Originally Added On: December 18th, 2011]
- Biotechnology: Boon to Human being [Last Updated On: December 18th, 2011] [Originally Added On: December 18th, 2011]
- Philippines banks on biotechnology to deal with enviromentally friendly issues, food security considerations [Last Updated On: December 18th, 2011] [Originally Added On: December 18th, 2011]
- Philippines banks on biotechnology to deal with enviromentally friendly issues, food security considerations [Last Updated On: December 18th, 2011] [Originally Added On: December 18th, 2011]
- Biotechnology: Boon to Human being [Last Updated On: December 18th, 2011] [Originally Added On: December 18th, 2011]
- Growth and development of Biotechnology [Last Updated On: December 18th, 2011] [Originally Added On: December 18th, 2011]
- Biotechnological innovation on Farming Skill [Last Updated On: December 18th, 2011] [Originally Added On: December 18th, 2011]
- Curing the entire world through biotechnology [Last Updated On: December 18th, 2011] [Originally Added On: December 18th, 2011]
- Scientists make ethical stem cells from skin of a rat [Last Updated On: January 22nd, 2012] [Originally Added On: January 22nd, 2012]
- India emerging as a global hub for stem cell research [Last Updated On: January 22nd, 2012] [Originally Added On: January 22nd, 2012]
- India emerging as a global hub for stem cell research [Last Updated On: January 22nd, 2012] [Originally Added On: January 22nd, 2012]
- Scientists make ethical stem cells from skin of a rat [Last Updated On: January 22nd, 2012] [Originally Added On: January 22nd, 2012]
- Alzheimer Disease - New Drugs, Markets and Companies [Last Updated On: January 31st, 2012] [Originally Added On: January 31st, 2012]
- Amazing Stem Cell Therapy Results | Before [Last Updated On: January 31st, 2012] [Originally Added On: January 31st, 2012]
- Stemcell therapy for pets - Mi Mascota - Video [Last Updated On: January 31st, 2012] [Originally Added On: January 31st, 2012]
- Stem cells for dogs? New pain management therapy works for pets - Video [Last Updated On: January 31st, 2012] [Originally Added On: January 31st, 2012]
- Riot's Lameness Moving Exam Pre Stem Cell Therapy - Video [Last Updated On: January 31st, 2012] [Originally Added On: January 31st, 2012]
- Riot's Lameness Palpation Exam Pre Stem Cell Therapy - Video [Last Updated On: January 31st, 2012] [Originally Added On: January 31st, 2012]
- Ariel's Stem Cell Miracle! - Video [Last Updated On: January 31st, 2012] [Originally Added On: January 31st, 2012]
- South Korea again gives a go ahead to use of human eggs in cloning research [Last Updated On: February 5th, 2012] [Originally Added On: February 5th, 2012]
- South Korea again gives a go ahead to use of human eggs in cloning research [Last Updated On: February 5th, 2012] [Originally Added On: February 5th, 2012]
- Angel Biotechnology - Contracts with Materia Medica [Last Updated On: February 7th, 2012] [Originally Added On: February 7th, 2012]
- Cellerant Therapeutics Appoints Lowell E. Sears to Board of Directors [Last Updated On: February 21st, 2012] [Originally Added On: February 21st, 2012]
- Angel Biotechnology - Grant of Share Options [Last Updated On: February 27th, 2012] [Originally Added On: February 27th, 2012]
- RBCC Closes Deal with Game Changing Biotech Firm [Last Updated On: March 16th, 2012] [Originally Added On: March 16th, 2012]
- The year of the dragon looks auspicious for Australian Biotechnology [Last Updated On: March 25th, 2012] [Originally Added On: March 25th, 2012]
- The year of the dragon looks auspicious for Australian Biotechnology [Last Updated On: March 25th, 2012] [Originally Added On: March 25th, 2012]
- David Allan Lauded for Leadership – Biotechnology Leader Named to Industry Award [Last Updated On: May 9th, 2012] [Originally Added On: May 9th, 2012]
- Angel Biotechnology - Angel signs new contract with ReNeuron [Last Updated On: May 17th, 2012] [Originally Added On: May 17th, 2012]
- MYOS Names Veteran Biotechnology Executive Dr. Sol J. Barer to Chair Scientific Advisory Board [Last Updated On: June 27th, 2012] [Originally Added On: June 27th, 2012]
- StemCells and Keryx Biopharmaceuticals Showing Strong Gains as Biotechnology Industry Soars in 2012 [Last Updated On: July 24th, 2012] [Originally Added On: July 24th, 2012]
- Osiris Therapeutics and Pluristem Therapeutics Showing Impressive Growth as Biotech Industry Thrives in 2012 [Last Updated On: August 4th, 2012] [Originally Added On: August 4th, 2012]
- Allele Biotechnology Announces New Advance in Production of Human Stem Cells [Last Updated On: September 14th, 2012] [Originally Added On: September 14th, 2012]
- BIO Announces Therapeutic Workshops for 11th Annual BIO Investor Forum [Last Updated On: September 25th, 2012] [Originally Added On: September 25th, 2012]
- Biotech Industry Applauds Introduction of the High Technology Small Business Research Incentives Act [Last Updated On: October 2nd, 2012] [Originally Added On: October 2nd, 2012]
- Biotech Industry Look to Benefit From New Act Designed to Promote R&D Joint Ventures [Last Updated On: October 15th, 2012] [Originally Added On: October 15th, 2012]
- David Lichtenstein: Biotechnology is Rich Area for Investment [Last Updated On: November 2nd, 2012] [Originally Added On: November 2nd, 2012]
- Donna Dickenson introduces Bioethics - Video [Last Updated On: November 2nd, 2012] [Originally Added On: November 2nd, 2012]
- Coare Biotechnology and ChemDiv Establish Co-Marketing and Service Collaboration [Last Updated On: November 9th, 2012] [Originally Added On: November 9th, 2012]
- blood banks | Umbilical Cord Blood Banking Could Be an Investment in Our Future Health - Video [Last Updated On: November 12th, 2012] [Originally Added On: November 12th, 2012]
- Research and Markets: Research Report on the Biotechnology Market in India 2012 [Last Updated On: November 18th, 2012] [Originally Added On: November 18th, 2012]
- Life Un(Ltd), Charis Thompson, Three Times a Woman- A Gendered Economy of Stem Cell Innovation Pt. 2 - Video [Last Updated On: November 30th, 2012] [Originally Added On: November 30th, 2012]
- Life UnLtd, Charis Thompson, Three Times a Woman A Gendered Economy of Stem Cell Innovation Pt 1 - Video [Last Updated On: November 30th, 2012] [Originally Added On: November 30th, 2012]
- Biotechnology: Things you should know about Gene Therapy [Last Updated On: December 2nd, 2012] [Originally Added On: December 2nd, 2012]
- Biotechnology: Things you should know about Gene Therapy [Last Updated On: December 2nd, 2012] [Originally Added On: December 2nd, 2012]
- Top trends for Biotechnology [Last Updated On: December 9th, 2012] [Originally Added On: December 9th, 2012]
- Top trends for Biotechnology [Last Updated On: December 9th, 2012] [Originally Added On: December 9th, 2012]
- Angel Biotechnology losses widen [Last Updated On: December 10th, 2012] [Originally Added On: December 10th, 2012]
- Why Biotech ETFs are a Top Sector in 2012 [Last Updated On: December 19th, 2012] [Originally Added On: December 19th, 2012]
- Things to know about the real fountain of youth [Last Updated On: January 11th, 2013] [Originally Added On: January 11th, 2013]
- Things to know about the real fountain of youth [Last Updated On: January 20th, 2013] [Originally Added On: January 20th, 2013]
- DNA testing is Good or Bad: Let’s Discuss [Last Updated On: March 2nd, 2013] [Originally Added On: March 2nd, 2013]
- Computer Review Announces New Tools to Deal with the Flood of Information from the Biotechnology Sector [Last Updated On: March 7th, 2013] [Originally Added On: March 7th, 2013]
- DNA testing is Good or Bad: Let’s Discuss [Last Updated On: March 10th, 2013] [Originally Added On: March 10th, 2013]
- The Mystery about Cyanide Taste [Last Updated On: March 31st, 2013] [Originally Added On: March 31st, 2013]
- The Mystery about Cyanide Taste [Last Updated On: April 14th, 2013] [Originally Added On: April 14th, 2013]
- Are Biodegradable Heart Stents Safe? [Last Updated On: April 17th, 2013] [Originally Added On: April 17th, 2013]
- Piper Jaffray Biotechnology Analyst Participates in Historical Medical Event at the Vatican [Last Updated On: April 17th, 2013] [Originally Added On: April 17th, 2013]
- Are Biodegradable Heart Stents Safe? [Last Updated On: April 21st, 2013] [Originally Added On: April 21st, 2013]
- TaiGen Biotechnology Announces Submission of New Drug Application for Nemonoxacin in Taiwan and Mainland China [Last Updated On: May 17th, 2013] [Originally Added On: May 17th, 2013]
- How good to use home pregnancy tests [Last Updated On: June 1st, 2013] [Originally Added On: June 1st, 2013]
- How good to use home pregnancy tests [Last Updated On: June 2nd, 2013] [Originally Added On: June 2nd, 2013]
- Questions you should ask to doctor for Alzheimer disease [Last Updated On: July 6th, 2013] [Originally Added On: July 6th, 2013]
- Questions you should ask to doctor for Alzheimer disease [Last Updated On: July 7th, 2013] [Originally Added On: July 7th, 2013]
- BetaStem Therapeutics Retains Conditas Biotechnology Group for Business Development and Corporate Strategy [Last Updated On: July 18th, 2013] [Originally Added On: July 18th, 2013]
- Sanguine BioSciences Announces Distribution Partnership with AMS Biotechnology [Last Updated On: August 8th, 2013] [Originally Added On: August 8th, 2013]
- Matric Revision: Life Sciences: Genetics: Biotechnology (5/9): Cloning (1/4) - Video [Last Updated On: October 27th, 2013] [Originally Added On: October 27th, 2013]
- Matric Revision: Life Sciences: Genetics: Biotechnology (6/9): Cloning (2/4) - Video [Last Updated On: October 29th, 2013] [Originally Added On: October 29th, 2013]
- History of biotechnology - Wikipedia, the free encyclopedia [Last Updated On: December 16th, 2013] [Originally Added On: December 16th, 2013]
- Exciting business ideas in biotechnology and healthcare - Video [Last Updated On: February 19th, 2014] [Originally Added On: February 19th, 2014]
- Crippled canines get new leash on life [Last Updated On: March 27th, 2014] [Originally Added On: March 27th, 2014]
- Stem Cell Treatment for Dogs - pet insurance [Last Updated On: March 27th, 2014] [Originally Added On: March 27th, 2014]
- New patenting guidelines needed for biotechnology, experts argue [Last Updated On: April 24th, 2014] [Originally Added On: April 24th, 2014]
- New tumor-targeting agent images and treats wide variety of cancers [Last Updated On: June 24th, 2014] [Originally Added On: June 24th, 2014]
- San Diego Hosts World's Largest Biotechnology Convention - Video [Last Updated On: June 28th, 2014] [Originally Added On: June 28th, 2014]
- Shot in the arm for research on disease biology [Last Updated On: July 13th, 2014] [Originally Added On: July 13th, 2014]
- biotechnology -- Encyclopedia Britannica [Last Updated On: August 28th, 2014] [Originally Added On: August 28th, 2014]